Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can kids with allergies use nasal spray only when needed? new study investigates.

NCT ID NCT05299086

Symptom relief Sponsor: Mahidol University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether children with year-round allergic rhinitis can use a nasal steroid spray only when symptoms bother them, instead of every day. Sixty-eight children aged 6 to 18 were randomly assigned to either daily use or as-needed use of fluticasone furoate spray. The goal was to compare how well each approach controls nasal symptoms like sneezing, itching, runny nose, and congestion, and to see if as-needed use reduces side effects and total drug exposure.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Fluticasone furoate nasal spray
What this could lead to
If it works, this could show that using the spray only when symptoms flare is just as effective as daily use, with fewer side effects and lower total drug exposure.
What could go wrong
This is a small, completed Phase 3 trial with only 68 children, so results may not apply to all kids. The as-needed approach might not control symptoms as well in more severe cases.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

68 people

The number who actually took part.

Started

Apr 2022

Finished

Apr 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 18 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children patient (age 6 - 18 yr) * Mild persistent, Moderate to severe intermittent and persistent perennial allergic rhinitis * Rhinitis proven sensitization to aeroallergen by positive skin prick test or specific IgE result within 12 month before study recruitment * Mean TNSS = 4 during 7 day duration before randomization (after a washout period, discontinuation of the medications listed in exclusion criteria Exclusion Criteria: * Patients with rhinosinusitis, nasal polyps, or significant deviated nasal septum * Patients with a history of uncontrolled asthma, chronic lung disease, cardiovascular, hepatic, or renal diseases * Patients taking oral or nasal decongestants within 7 d * Patients taking INCS within 4 week * Patients taking systemic corticosteroid within 8 week * Patients taking H1 antihistamine within 1 week * Patients taking antileukotriene within 4 week * Patients who were currently or previously treated with allergen immunotherapy * Patients with a history of upper respiratory tract infection within 14 d * Patients with primary and secondary immune deficiency

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Child, only are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

CHILD syndrome perennial allergic rhinitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Child, only Perennial allergic rhinitis

Contacts and locations

Locations

  • Division of Allergy and Immunology, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University

    Bangkok, Bangkok, 10700, Thailand

More trials for these conditions

Other studies related to the condition(s) this trial covers.